Crispr Therapeutics (CRSP) Stock Price
$56.26 0.7%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
7 -
Technical
7
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Crispr Therapeutics, AI stock picks, stock alerts and much more.
CRSP AI Stock Analysis
AI stock analysis for CRSP is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Crispr Therapeutics (CRSP) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Crispr Therapeutics (CRSP) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Crispr Therapeutics (CRSP), currently trading at $56.26, will... Sign up to access price prediction.
About CRSP
-
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.
-
Symbol
CRSP
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
5.1B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$19.97 1.4% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.38 10.2% |
2 |
 |
Moderna MRNA |
$23.51 7.4% |
4 |
 |
Anavex Life Sciences AVXL |
$9.37 2.2% |
5 |
 |
BridgeBio Pharma BBIO |
$51.21 2.6% |
6 |
News
CRSP Alternative Data
Web Traffic
Crispr Therapeutics receives an estimated 117983 monthly visitors to crisprtx.com, which is down by -3.3% over the last month.
-
Web Traffic
117983
-
Change from Previous Month
3.3%
-
3 Month Change
39.8%
-
YoY Change
39.8%
Twitter Followers
Crispr Therapeutics has 23,177 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.5% over the last month.
-
Twitter Followers
23177
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
2%
-
YoY Change
2%
LinkedIn Followers
103,240 are following Crispr Therapeutics on LinkedIn, up by 0.9% over the last month.
-
LinkedIn Followers
103240
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
2.9%
-
YoY Change
2.9%
Job Postings
Crispr Therapeutics currenly has an estimated 7 open job postings.
-
Job Postings
7
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
75%
-
YoY Change
75%
LinkedIn Employees
According to LinkedIn, Crispr Therapeutics has 374 employees, down by -1.8% over the last month.
-
LinkedIn Employees
374
-
Daily Change
0%
-
1 Month Change
1.8%
-
3 Month Change
7.4%
-
YoY Change
7.4%
Reddit Mentions
Crispr Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Crispr Therapeutics is 40 out of 100 (bearish), down by -2.4% over the last month.
-
Business Outlook
40
-
Change from Previous Month
2.4%
-
3 Month Change
2.4%
-
YoY Change
2.4%
Reddit Sentiment
The sentiment Score for Crispr Therapeutics is 56 out of 100, which represents a neutral sentiment.
-
Reddit Sentiment
56
-
Daily Change
36%
-
1 Month Change
0%
News Mentions
Crispr Therapeutics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
80%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
CRSP Financials
CRSP Key Metrics
-
Total Revenue
$35M
-
Net Income
-$37.3M
-
Earnings per Share
-$0.44
-
Free cash flow
-$50.3M
-
EBITDA
-$59.7M
-
EBITDA Ratio
-1.70703
-
Total Assets
$2.2B
CRSP 2-year Revenue & Income
CRSP 2-year Free Cash Flow
CRSP Technicals
CRSP SMA
CRSP RSI
FAQ
What's the current price of Crispr Therapeutics (CRSP) Stock?
The price of an Crispr Therapeutics (CRSP) share is $56.26.
What's the market cap of Crispr Therapeutics?
The current market cap of Crispr Therapeutics is 5.1B.
What are some stocks similar to Crispr Therapeutics (CRSP) that investors often compare it to?
Crispr Therapeutics (CRSP) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Crispr Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Crispr Therapeutics' stock price to be around $56.08 in 2026. Starting from the current price of $56.26, this represents a 0.3% change in price, indicating a neutral outlook for the stock.
How to buy Crispr Therapeutics (CRSP) Stock?
Crispr Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Crispr Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.